High Throughput Screening Market by Technology, Application, Product & End User - 2027

The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of government funding and venture capital investments.

The report "High Throughput Screening Market is expected to reach USD 29.29 billion by 2027 from an estimated USD 14.95 billion in 2019, at a CAGR of 7.8%.

HTS Market Drivers: -
                  1Growing Adoption of Open Innovation Models in Pharmaceutical and    Biotechnology Companies
                 2 Government Funding and Venture Capital Investments
                 3 Increasing R&D Spending
                 4 Technological Advancements

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950

The report analyzes the global HTS market by product & service, technology, application, end user, and region. On the basis of product & service, the reagents & assay kits segment accounted for the largest share of the global HTS market in 2017. Factors such as the large numbers of reagents and assay kits used in HTS techniques, rising prevalence of a number of diseases, increasing pharmaceutical R&D, and increased government funding for life science research are driving the growth of this segments.

Geographic Analysis

• Further breakdown of the Rest of APAC high-throughput screening market into Australia, New Zealand, Singapore, and others
• Further breakdown of the Rest of Europe high-throughput screening market into Belgium, Russia, the Netherlands, Switzerland, and others

Read More: - https://www.marketsandmarkets.com/PressReleases/high-throughput-screening.asp

 Key players:-

The prominent players in the global HTS market are Agilent (US), Danaher (US), Thermo Fisher Scientific (US), PerkinElmer (US), Tecan (Switzerland), Axxam (Italy), Merck Group (Germany), Bio-Rad (US), Hamilton (US), Corning (US), BioTek (US), and Aurora Biomed (Canada).

Hospitals & Clinics are the Largest End Users of Ventilators

Factors such as increasing number of preterm births, rapid growth in the geriatric population, rising prevalence of respiratory diseases, and rising number of ICU beds are expected to drive the growth of the ventilators market during the forecast period. In addition, the growing demand for home care therapeutics and higher growth in developing countries like China, India, and Brazil are driving the demand for ventilators.

The report "Ventilator Market is projected to reach USD 1.72 billion by 2027 from USD 0.93 billion in 2019, at a CAGR of 8.0%.

Market Drivers: -
                    1 Rising Prevalence of Respiratory Diseases
                              1.1 Urbanization and Growing Pollution Levels
                              1.2 High Prevalence of Tobacco Smoking
                              1.3 Changing Lifestyles
                   2 Rapid Growth in the Geriatric Population
                   3 Increasing Number of Preterm Births
                   4 Rising Number of ICU Beds

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11018337

The report analyzes the global ventilator market by mobility, mode, interface, type, end user, and region.

On the basis of mobility, the intensive case ventilators segment accounted for the largest share of the global ventilators market. The large share of this segment is attributed to the rising number of ICU beds and rising adoption of equipping the ICU beds with ventilators.
On the basis of interface, the invasive ventilation segment accounted for the largest share of the ventilators market. The large share of this segment is due to the high prevalence of tobacco smoking, increasing prevalence of chronic diseases such as COPD & asthma, rapid growth in the geriatric population, and improving healthcare affordability in developed countries.
Based on end user, the hospitals & clinics segment accounted for the largest share of the ventilators market. The large share of this segment can be attributed to the increasing number of private and public hospitals, economic expansion and focus of government on broader healthcare policies, and increasing per capita income.
Based on type, the adult/pediatric ventilators segment held the largest market share of ventilators market.

Read More: -  https://www.marketsandmarkets.com/PressReleases/ventilators.asp

Regional Analysis:-

North America accounted for the largest share of the ventilators market in 2018, followed by Europe and Asia Pacific. The presence of major market players, the rising geriatric population, and high prevalence of smoking, high prevalence of respiratory diseases, highly developed healthcare system, and high healthcare expenditure are the other factors responsible for the large share of North America in the ventilators market.

Key Players:-

The prominent players in the global ventilators market are Philips Healthcare (Netherlands), ResMed (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Getinge (Sweden), Dräger (Germany), Smiths Group (UK), Hamilton Medical (Switzerland), GE Healthcare (US), Fisher & Paykel (New Zealand), Air Liquide (France), Zoll Medical (US), Allied Healthcare Products (US), Airon (US), Mindray (China), and Schiller (Switzerland).

Hemodialysis Products Segment to Lead the Dialysis Market across All Regions By 2024

Growth in this market is driven by the increasing number of ESRD patients, growing prevalence of diabetes & hypertension, shortage of organ donors and risks associated with transplant, technological advancements and new product launches, and rising R&D expenditure for developing new dialysis products.
The Hemodialysis & Peritoneal Dialysis Market is projected to reach USD 99.2 billion by 2024 from USD 74.2 billion in 2019, at a CAGR of 6.0%

Recent Developments

• In 2019, Fresenius Medical Care acquired NxStage Medical, Inc. (a US-based leader in the home dialysis segment). With this acquisition, the company aims to expand its presence in the dialysis market
• In 2018, Fresenius Medical Care acquired 70% shares of Guangzhou KangNiDaiSi Medical Investment Co., Ltd. company to expand its dialysis care network in China
• In 2018, B. Braun Melsungen AG opened a production site for dialyzers in Saxony (Germany) aimed to increase the access to advanced dialysis products in the country.
• In 2017, DaVita acquired Purity Dialysis (US) to expand its dialysis care business in the US.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279

The global hemodialysis market is broadly categorized into two segments, namely, hemodialysis products and hemodialysis services market. The hemodialysis products market includes machines (center-use & home-use machines) & consumables (dialyzers, access products, bloodlines, dialysates, and other consumables). The hemodialysis services (including in-center & home- hemodialysis services) segment is expected to account for the largest share of the hemodialysis market. The increasing number of dialysis centers coupled with the growing prevalence of ESRD is the major factor driving the growth of the hemodialysis services market.

The peritoneal dialysis market, by modality, includes continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). The APD segment is expected to grow at the highest CAGR owing to its several advantages over CAPD, such as daytime freedom for patients, fewer connections and disconnections (and hence a lower probability of peritonitis), and improved quality of life. Being automated, APD is also the preferred dialysis treatment for the elderly and children.

Regional Analysis:-

Based on region, the hemodialysis and peritoneal dialysis market has been segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the hemodialysis and peritoneal dialysis market in 2019. The higher per capita income as compared to other regions, favorable reimbursement scenario, and increasing demand for dialysis procedures are propelling the growth of the market.
Read more: - https://www.marketsandmarkets.com/PressReleases/dialysis.asp

Key Players:-

The major players operating in the global hemodialysis and peritoneal dialysis market are Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (US), Baxter International, Inc. (US), and B. Braun Melsungen AG (Germany).

Ultrasound, Radiography, MRI and Video Endoscopy is Increasing Demand of Veterinary Imaging Market

The growth of the market during the forecast period is mainly driven by the increase in animal healthcare spending, growing pet insurance purchase, the growing companion animals market, increase in the number of veterinary practitioners and their income levels in developed regions, and launch of portable battery charge imaging instruments. However, the high cost of veterinary imaging instruments and increasing pet care expenditure are expected to restrain the overall market growth, to a certain extent, during the forecast period.

The Veterinary Imaging Market is expected to reach USD 1.94 Billion by 2022 from an estimated USD 1.40 Billion in 2017, at a CAGR of 6.8%.

In this report, the global veterinary imaging market is segmented by product, therapeutic area, animal, end user, and region. On the basis of product, the global veterinary imaging market is segmented into instruments, reagents, and software. The veterinary imaging instruments segment includes radiography systems, ultrasound imaging systems, magnetic resonance imaging (MRI) systems, computed tomography (CT) imaging systems, video endoscopy imaging systems, and other imaging systems (including thermal imaging systems and optical coherent tomography).
The radiography systems segment accounted for the largest share of the global veterinary imaging instruments market in 2016.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80889726   

On the basis of therapeutic area, the global veterinary imaging market is segmented into orthopedics & traumatology, oncology, cardiology, neurology, and other therapeutic areas. The orthopedics & traumatology segment accounted for the largest share of the global veterinary imaging market in 2016. The large share of this segment can be attributed to the increasing incidence of bone injuries and rising prevalence of arthritis and lameness disease in animals. Oncology application segment offers significant growth opportunities in the market.

Based on animal type, the global veterinary imaging market is segmented into small companion animals, large animals, and other animals. The small companion animals segment accounted for the largest share of the market in 2016. The large share and growth of this segment are attributed to the increasing adoption of companion animals, rising animal healthcare expenditure, growing demand for pet insurance in developed countries, and increasing incidence of disease outbreaks in companion animals.

The global veterinary imaging market, by end user, is segmented into clinics and hospitals & academic institutions. Clinics are the major end users in the veterinary imaging market and accounted for a share in 2016.

Regional Analysis:-
North America represented the largest veterinary imaging market in 2016, followed by Europe and Asia-Pacific. The Asia-Pacific market is expected to register the highest CAGR during the forecast period. Factors such as large increasing awareness about animal health in APAC countries, growth in pet adoption, and growing per capita animal health expenditure, especially in India and China, are contributing to the growth of the APAC veterinary imaging market.

Read more @ https://www.marketsandmarkets.com/PressReleases/veterinary-imaging.asp  

Key players:-
The major players in the global veterinary imaging market are GE Healthcare (U.S.), Agfa- Gevaert N.V. (Belgium), Excelsior Union Limited (Russia), Onex Corporation (Canada), Esaote S.p.A (Italy), Canon Inc. (Japan), IDEXX Laboratories, Inc. (U.S.), VCA Inc. (U.S.), Hitachi, Ltd (Japan), BCF Technology, Ltd. (U.K.), Siemens AG (Germany), Diagnostic Imaging Systems, Inc. (U.S.), Hallmarq Veterinary Imaging Ltd. (U.K.), MinXray, Inc. (U.S.), and Fujifilm Holdings Corporation (Japan).

The Global CT Scanner Market is projected to reach USD 6.20 Billion by 2022, at a CAGR of 5.4%

Major factors driving the growth of this market include growing need for effective and early diagnosis, rising global prevalence of targeted diseases coupled with an aging population, increasing preference for minimally invasive diagnostic procedures, increasing benefits of CT scans over other imaging modalities, and technological advancements. However, significant installation and maintenance costs, uncertain reimbursement scenario across developing nations, dearth of well-trained and skilled healthcare professionals may hinder the growth of the CT scanner market during the forecast period.

The Global CT Scanner Market is projected to reach USD 6.20 Billion by 2022, at a CAGR of 5.4% during the forecast period.

Download PDF Brochure: - http://www.marketsandmarkets.com/pdfdownload.asp?id=184364345

Major Market Developments:

• In 2017, GE Healthcare introduced a dedicated cardiovascular CT system, namely, CardioGraphe which creates 3D images of coronaries, valves, chambers and myocardium in one heartbeat.
• In 2017, Toshiba, signed a three-year pricing agreement with Varex Imaging Corporation in order to supply CT tubes for integration into Toshiba’s CT systems
• In 2017, Siemens signed an agreement with HeartFlow for the integration of Siemens’s CT scanner systems with HeartFlow’s FFRct Analysis.
• In 2017, Hiatchi, signed an agreement with Redlen Technologies for the development of a multi-energy photon-counting Computed tomography (PCCT) semiconductor detector module

On the basis of technology, the CT scanners market is segmented into high-slice CT, mid-slice CT, low-slice CT, and cone beam CT technology. The cone beam CT technology segment is expected to grow faster than the other segments during the forecast period, majorly due to factors like procedural advantages; rising market demand for cosmetic dentistry; and ongoing product development & commercialization across major healthcare markets.
Based on type, the CT scanners market is divided into stationary and portable CT scanners. Portable CT scanners segment is poised to grow faster than the other segment due to increasing number of device installations across major markets, growing application horizons, and the lower switching costs provided by portable CT scanners.

Geographical Analysis:-                

Geographically, the CT scanner market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2017, which is primarily driven by growth in the aging U.S. population; an increasing public emphasis on minimally invasive & effective disease management strategies; robust reimbursement scenario; increasing adoption of novel applications; and rising public-private investments.

Read more: - https://www.marketsandmarkets.com/PressReleases/ct-scanner.asp

Top Key players:-
The major players in the CT scanner market are Koninklijke Philips N.V. (Netherlands), GE Healthcare (U.S.), Toshiba Corporation (Japan), Siemens AG (Germany), Hitachi Ltd. (Japan), Shimadzu Corporation (Japan), Samsung Electronics Co., Ltd. (South Korea), Neusoft Medical Systems Co., Ltd. (China), Medtronic plc (Ireland), Shenzhen Anke High-tech Co., Ltd. (Hong Kong), Accuray Incorporated (U.S.), PlanMED (Finland), Koning Corporation (U.S.), Carestream Health Inc. (U.S.), and PointNix Co. Ltd (South Korea).